Late-Stent Throbosis Risk after Clopidogrel Withdrawal: Greater in Drug Eluting Stents

matthias pfisterer Late Stent Throbosis Risk after Clopidogrel Withdrawal: Greater in Drug Eluting Stents
Matthias Pfisterer, University Hospital Basel
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 422-11. Lancet 2005:366:921
Clopidogrel therapy may need to be prolonged among patients treated with angioplasty plus drug eluting stent implantation as compared with those getting bare metal stents. That’s the outcome of the BASKET (Basel Stent Cost Effectiveness Trials) study announced at the American College of Cardiology conference in Atlanta. Sarah Maxwell heard results from Matthias Pfisterer from Basel.

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

This entry was posted in ACC 2006 and tagged , , . Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>